GRAIL, Inc. Common Stock

GRALNASDAQ • USD
139.91 USD
↗ 7.36 (5.55%)AT CLOSE (03:59 PM EDT)
141.34
↗ 1.43 (1.02%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
141.34
↗ 1.43 (1.02%)
🔴Market: CLOSED

GRAIL, Inc. Common Stock (GRAL) trades at $139.92 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place GRAL at a fair price relative to peers.

Technical & fundamental data as of Oct 26, 2026.

Open?$134.83
High?$141.68
Low?$132.75
Prev. Close?$132.55
Volume?891.4K
Avg. Volume?1.4M
VWAP?$139.28
Rel. Volume?0.66x
Bid / Ask
Bid?$119.11 × 100
Ask?$161.03 × 100
Spread?$41.92
Midpoint?$140.07
Valuation & Ratios
Market Cap?5.9B
Shares Out?44.7M
Float?42.4M
Float %?95.0%
P/E Ratio?N/A
P/B Ratio?2.33
EPS?-$8.77
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Employees
910
Market Cap
5.9B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2024-06-12
Address
1525 O'BRIEN DRIVE
MENLO PARK, CA 94025
Phone: (833) 694-2553
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
88
Short Sent.?
45
Piotroski F-Score?3/9Weak
Altman Z-Score?9.31Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.27%High
Short Interest?8.2M
Days to Cover?8.0
Free Float42.4M
Avg Daily Volume1.0M
Settlement Date2026-10-15
Financial Health
Current Ratio?10.95Strong
Quick Ratio?10.74Strong
Cash Ratio?0.67Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
67
2.33CHEAP▾
P/S?
Peers
100
S&P
3
35.82HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-15.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
35.49HIGH▾
Returns & Efficiency
ROE?
S&P
8
-15.4%WEAK▾
ROA?
S&P
3
-13.8%WEAK▾
Cash Flow & Enterprise
FCF?$-296162000
Enterprise Value?$5.9B
Fundamentals ratios updated end of day